+377.1%
MRNA vs MDLN
+4.5%
+372.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MDLN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | 0.0% | -2.2% | -2.2% |
| 7D | +5.5% | +3.7% | +1.8% | +4.8% |
| 30D | +158.7% | -0.2% | +158.9% | +158.0% |
| 3M | +182.1% | +6.2% | +175.9% | +185.7% |
| 6M | +151.8% | -14.7% | +166.5% | +150.9% |
| YTD | +393.6% | -12.9% | +406.4% | +391.1% |
| All | +377.1% | +4.5% | +372.5% | +373.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MDLN.
Daily Out/Under-Performance
Portfolio return minus MDLN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MDLN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MDLN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling